40 Minimally Invasive Surgery Statistics: Procedure Types, Market Value and End-User Adoption
40 Minimally Invasive Surgery Statistics:
Procedure Types, Market Value and End-User Adoption
Miriam Otero
13 min
June 30, 2024
Did you know that minimally invasive procedures account for nearly 70% of all global surgeries today? These innovative techniques involve smaller incisions and specialized tools, leading to less pain, fewer complications, and shorter hospital stays, such as Medical Needling, Lip Fillers, and Sweat Treatments, to name a few.
As a result, patients can return to their daily activities much sooner. Whether used for diagnostic purposes or surgical interventions, minimally invasive procedures are at the forefront of modern healthcare, prioritizing patient comfort and efficiency. Discover how these advancements are transforming medical treatment and improving patient outcomes.
HAIR & SKIN offers the chance to enhance your unique beauty. Their natural treatments infuse your face with new vitality and boost your confidence.
Top 10 Minimally Invasive Surgery Statistics
In 2024, robotic surgery simulation platforms are projected to account for approximately 74% of the global robotic surgical simulation systems market. [Source: 7]
The industry's growth is propelled by the pivotal roles of Artificial Intelligence (AI) and highly skilled healthcare professionals. Together, they account for 50% of market demand and a year-on-year growth rate of 5.1% between 2022 and 2032. [Source: 1]
The hospitals segment commands 73.3% of the global minimally invasive surgical systems market, driven by the extensive availability of surgical treatments in hospitals. [Source: 11]
The U.S. has over 5,480 Medicare-certified ambulatory surgery centers. [Source: 10]
Chronic diseases pose a significant healthcare challenge in the U.S., with annual total costs now reaching $3.7 trillion, or approximately 19.6% of the country's GDP. [Source: 2]
The FDA has approved robotic surgery for over 50 weight loss, cardiothoracic, and gynecology procedures. This approval will drive the demand for robot-assisted minimally invasive surgeries in the coming years. [Source: 1]
The global market is segmented by end-use into hospitals and ambulatory surgical centers (ASCs). In 2023, hospitals accounted for the largest revenue share at 68.8%, driven by increased chronic disorders among the elderly, leading to more hospital admissions for treatment. [Source: 10]
The Australian Bureau of Statistics' March 2022 update indicated that heart disease affected 4.0% of the Australian population, equating to 1.0 million people in 2021. Surgical robots and robot-controlled tools enable less invasive procedures than traditional open surgery, which is expected to drive market growth from 2024 to 2029. [Source: 14]
In 2023, the handheld instruments segment, with its 22.1% revenue share, was the undisputed leader in the market. These instruments are crucial in minimizing damage to surrounding tissues, enhancing patient recovery, and reducing discomfort. Most minimally invasive surgery handheld instruments are single-use, underlining their significance in the market. [Source: 10]
Da Vinci Surgical System is a robotic system used in robotic surgery. It comprises an operating console, a separate video screen, and an equipment cart holding the instruments and camera. The console controls four robotic arms. Introduced in 2000, it is the first robotic surgery system to be FDA-approved for minimally invasive surgeries. [Source: 15]
Minimally Invasive Surgery Market Statistics
The industry has seen tremendous growth and is changing modern medicine by offering sophisticated technologies that streamline surgical procedures. These MIS approaches are increasingly indispensable in various disciplines, including orthopedics and cardiology. With forecasts of 7.43%, CAGR is estimated to grow to $$6.1 million by 2032 with a consistent consumer base.
The minimally invasive surgery industry was valued at $6.3 billion in 2022. It is projected to grow at a CAGR of 5.2% from 2022 to 2032, reaching $10.5 billion by the end of 2032. [Source: 1]
In 2023, the global automated suturing devices market was valued at $3.2 million. It is projected to reach $6.1 million by 2032, growing at a CAGR of 7.43% during the forecast period. [Source: 12]
China is expected to lead the Asian market through 2032, with a projected CAGR of 5%. [Source: 1]
The APAC market valuation is estimated to reach $7.8 billion by 2032, up from nearly $4.6 billion in 2021. [Source: 1]
Global sales of minimally invasive surgery equipment and services grew at a CAGR of around 4% between 2015 and 2021. [Source: 1]
In 2021, China's medical devices accounted for 5.7% of the country's Gross Domestic Product (GDP), growing to around 7% in 2020. [Source: 1]
The industry's growth is propelled by the pivotal roles of Artificial Intelligence (AI) and highly skilled healthcare professionals. Together, they account for 50% of market demand and a year-on-year growth rate of 5.1% between 2022 and 2032. [Source: 1]
The minimally invasive surgical instrument market was valued at $25.7 billion in 2023 and is projected to grow at a CAGR of 8.1% from 2024 to 2032. [Source: 3]
The minimally invasive surgery devices market was valued at $12.9 billion in 2022. It is expected to grow from $14.06 billion in 2023 to $28.483 billion by 2032, with a CAGR of 9.20% between 2023 and 2032. [Source: 2]
The orthopedic segment is also experiencing significant growth potential, with a projected CAGR of 4% until 2032. [Source: 1]
Chronic diseases pose a significant healthcare challenge in the U.S., with annual total costs now reaching $3.7 trillion, or approximately 19.6% of the country's GDP. [Source: 2]
North America led the market with a 29.9% share in 2023, attributed to a well-established healthcare infrastructure, favorable government reimbursement policies, and a high prevalence of chronic diseases. [Source: 10]
The Asia Pacific region is projected to experience the fastest CAGR, 10.8%, from 2024 to 2030 due to improved healthcare infrastructure and increased government initiatives. [Source: 10]
The global minimally invasive spine surgery market is projected to increase by $1.82 billion, with a CAGR of 9.27% from 2023 to 2028. [Source: 13]
In 2019, the North American market for minimally invasive neurosurgical systems was valued at nearly $154 million, making it the largest in the world. The European market followed with a value of $115.3 million, and the Asia Pacific market was worth $109.9 million. [Source: 6]
The MIS market, AI, and highly skilled healthcare professionals demonstrate their role when they are anticipated to generate 50% market demand and a year-on-year growth rate of 5.1% between 2022 and 2032.
While high initial costs and the need for specialised training pose challenges, continuous research and development investments and the shift towards value-based healthcare are expected to fuel further growth, making the MIS market poised for substantial expansion.
Minimally Invasive Surgery Procedural Statistics
Did you know that MIS has reduced patient recovery time by up to 50% compared to traditional surgical methods? This approach reshapes surgical practices by offering quicker recoveries, less pain, and minimal patient scarring. We'll review the latest advancements in MIS, showcasing developmental tools and innovative techniques that set new standards in the field.
In 2024, robotic surgery simulation platforms are projected to account for approximately 74% of the global robotic surgical simulation systems market. [Source: 7]
In 2022, approximately 28.3 million orthopedic procedures were conducted worldwide. [Source: 5]
Over the past two to three years, about 35% of all colorectal surgeries have been performed using robotic systems. [Source: 5]
Over 15 million laparoscopic surgeries are conducted each year, with an anticipated 1% annual increase over the next five years. [Source: 5]
The FDA has approved robotic surgery for over 50 procedures in weight loss, cardiothoracic, and gynecology fields. This approval will drive the demand for robot-assisted minimally invasive surgeries in the coming years. [Source: 1]
In 2022, over 8 million neuromodulator injections and minimally invasive cosmetic procedures were performed in the U.S., followed by over 1 million lip augmentation procedures. [Source: 8]
Over 408,000 noninvasive skin tightening procedures were done in 2022 in the U.S. [Source: 8]
ERNI has worked closely with a company to develop a high-precision robot for minimally invasive surgery. This advanced robot, designed for laparoscopic procedures, consists of two main components: the Console Unit (for surgeon control) and the Robotic Unit (for exceptionally accurately performing movements.)
With an unprecedented error margin of less than 1 mm, this robot is sure to reform various medical fields, including urology, gynecology, and gastrointestinal surgery. As a Class III Medical Device, it upholds the highest safety and quality standards. A dedicated team of 25 experts at ERNI oversees the software development lifecycle, ensuring seamless coordination and effective project management.
The robot aims to obtain a CE mark by mid-2024 in the preclinical assay phase. Future enhancements will include AI, computer vision, and data analysis. This collaboration is set to change surgery, making it safer and more efficient. [Source: 4]
Minimally Invasive Surgery Tools Statistics
Minimally invasive surgery relies on specialised tools and equipment that require specific training. A skilled surgical team must manage these tools, monitor machines, and make necessary adjustments during surgery. They assist at the operating table, placing instruments when the surgeon operates from the robotic console.
Some of the equipment used includes:
Endoscopes are long, narrow tubes with a lighted video camera at the end. They are available in various sizes for different body cavities and can be rigid or flexible. The global endoscopy market is projected to reach nearly $45 billion by 2027. [Source: 15]
Imaging Equipment includes monitors that display video from the endoscope and additional imaging technologies like ultrasound or fluoroscopy to locate the surgical site. Medical professionals perform over 30 million MRI scans annually. [Source: 15]
Endovascular Catheters are small catheters that travel through blood vessels, guided by wires and X-ray imaging, to the surgical site for operation. The global market for these devices is projected to grow at a CAGR of 7.3%, reaching approximately $20.6 billion by 2028. [Source: 15]
Trocars are tubes placed within keyhole incisions (ports) through which other surgical instruments, including endoscopes, are inserted. [Source: 15]
Insufflators deliver low-pressure carbon dioxide gas into body cavities to inflate them for better visibility and access. [Source: 15]
Inflatable balloons create space in specific areas without inflating the entire body cavity and are placed at the end of a trocar, endoscope, or catheter. [Source: 15]
Long, narrow instruments are designed to operate within confined spaces and are manipulated through trocars, endoscopes, or catheters. [Source: 15]
Da Vinci Surgical System is a robotic system used in robotic surgery. It comprises an operating console, a separate video screen, and an equipment cart holding the instruments and camera. The console controls four robotic arms. Introduced in 2000, it is the first robotic surgery system to be FDA approved for minimally invasive surgeries. [Source: 15]
Each piece of equipment significantly enhances the precision and efficiency of minimally invasive procedures.
In 2023, the handheld instruments segment, with its 22.1% revenue share, was the undisputed leader in the market. These instruments are crucial in minimizing damage to surrounding tissues, enhancing patient recovery, and reducing discomfort. Most minimally invasive surgery handheld instruments are single-use, underlining their significance in the market. [Source: 10]
The market is divided by application into cardiac, gastrointestinal, orthopedic, dental, cosmetic, vascular, thoracic, gynecological, urological, and others. Orthopedics was the largest application segment in 2023, with a 23.6% revenue share. [Source: 10]
Orthopedic surgery within the conventional technologies segment is projected to achieve the highest CAGR of 7.0% from 2021 to 2031. [Source: 11]
In 2019, Botulinum toxin treatment was the most popular minimally invasive procedure, with 7.7 million treatments performed, a 3% increase from 2018. Soft tissue fillers followed with 2.7 million procedures, and chemical peels ranked third with 1.38 million. [Source: 9]
A facelift, or rhytidectomy, is a surgical procedure to reduce visible facial and neck aging signs. Facelift procedures saw an 8% increase in 2022. [Source: 9]
The conventional technologies segment leads the global minimally invasive surgical systems market, holding an 80.4% share, primarily due to the rise in these procedures. [Source: 11]
In 2021, the Nature Public Health Emergency Collection Journal reported a 60% decline in robotic surgery due to the pandemic. However, the market has rebounded over the past two years as surgical procedures have resumed worldwide. [Source: 14]
Strategic partnerships and mergers & acquisitions are shaping and potentially transforming the surgical instruments market. For instance, in February 2023, Encision Inc. signed a Proof of Concept Services Agreement with Vicarious Surgical Inc. This collaboration is set to enhance the precision, control, and visualization of instruments in robotic-assisted minimally invasive surgery, a development that could potentially transform the industry. This exciting prospect is a testament to the dynamic nature of our industry and the potential for inventive advancements. [Source: 10]
HAIR & SKIN offers unique skin treatments that consist of various treatments in one. With a holistic approach to skincare, each kit is tailored to meet individuals’ needs, from improved texture to combatting the first signs of aging.
The advancement and adoption of MIS techniques have been improving outcomes. Integrating robotic systems will further enhance surgical precision and efficiency as technology evolves. The ongoing growth in this field highlights the importance of staying updated with the latest innovations and best practices. Embracing these advancements will be essential for healthcare professionals committed to providing the highest standards of care.
Minimally Invasive Surgery Demographics and End User Statistics
Did you know that MIS can reduce hospital stays by up to 60% compared to traditional methods? This exciting approach is reshaping patient care and surgical practices. Understanding the demographics and end-user outlook is vital for optimizing outcomes and resource allocation.
In France, around 24,305 laparoscopic hysterectomies and 110,848 laparoscopic cholecystectomies have been performed. [Source: 5]
The U.S. stands at the forefront of plastic surgery procedures globally, with a staggering 4.3 million surgeries performed in 2021. [Source: 9]
In comparison, South Korea had approximately 6,274 procedures per 100,000 people in the same year. [Source: 9]
According to the National Spinal Cord Injury Statistical Center (NSCISC), the U.S. sees an average of 54 traumatic spinal cord injury (tSCI) cases per million people annually, resulting in about 18,000 new tSCI cases each year. [Source: 13]
The global prevalence of cancer and cardiovascular diseases is poised to fuel the demand for surgical robots, which offer unparalleled accuracy and precision in surgeries. For instance, the American Cancer Society's Cancer Statistics 2023 report projects a staggering 1.9 million new cancer cases to be diagnosed in the U.S. in 2023, highlighting the potential of surgical robots in the healthcare landscape. [Source: 14]
Similarly, the Australian Institute of Health and Welfare (AIHW) 2021 report estimated 150,800 new cancer cases in Australia for 2021. [Source: 14]
The Australian Bureau of Statistics' March 2022 update indicated that heart disease affected 4.0% of the Australian population, equating to 1.0 million people in 2021. Surgical robots and robot-controlled tools enable less invasive procedures than traditional open surgery, expected to drive market growth from 2024 to 2029. [Source: 14]
The global market is segmented by end-use into hospitals and ambulatory surgical centers (ASCs). In 2023, hospitals accounted for the largest revenue share at 68.8%, driven by increased chronic disorders among the elderly, leading to more hospital admissions for treatment. [Source: 10]
The U.S. has over 5,480 Medicare-certified ambulatory surgery centers. [Source: 10]
The hospitals segment commands 73.3% of the global minimally invasive surgical systems market, driven by the extensive availability of surgical treatments in hospitals. [Source: 11]
The rising incidence of stomach cancer, obesity, and type II diabetes is expected to drive the demand for gastrointestinal surgeries. Stomach cancer has a high mortality rate in several countries, and obesity affects over 400,000 people with morbid obesity. Surgical interventions help reduce morbidity and mortality associated with these conditions and improve quality of life, significantly boosting the demand for gastrointestinal surgeries over the forecast period. [Source: 10]
Understanding the demographics and end-users of MIS is essential for adapting to the evolving healthcare landscape. These insights help medical professionals better serve patients and meet the increasing demand for MIS. As advancements continue, staying informed and embracing new techniques will be necessary for improving patient outcomes and maintaining high standards in surgical care.
Frequently asked questions
Is Minimally Invasive Surgery Safer Than Traditional Surgery?
In many ways, minimally invasive surgery is safer than traditional open surgery. Additionally, some individuals who are not suitable candidates for traditional open surgery may qualify for minimally invasive procedures. [Source: 15]
Are There Any Sedation Methods Used in Minimally Invasive Surgery?
While open surgery typically requires general anesthesia, some minimally invasive procedures do not. You might only need local anesthesia at the incision site, possibly combined with sedation to help you relax. [Source: 15]
Is Anyone Eligible For Minimally Invasive Surgery?
Individuals with particular heart and lung conditions may not be ideal candidates for laparoscopic surgery. This procedure involves inflating the abdominal cavity with gases to separate the abdominal wall from the organs, which can increase the risk of heart and lung complications in some patients. Your surgeon will evaluate your individual risk to determine the best approach. [Source: 15]
Does It Take Long To Recover After Minimally Invasive Surgery?
Recovery time is typically much quicker. You can often return home the same day as your procedure, and your smaller incisions usually heal within weeks instead of months. [Source: 15]
What Is The Biggest Benefit of Minimally Invasive Surgery?
Minimally invasive surgery is characterized by small incisions, if any. These incisions, made for endoscopes and surgical instruments, are typically half an inch or smaller. An incision may be slightly larger if an organ needs to be removed, or smaller if it's in the brain or vascular system. Smaller incisions lead to easier recovery, with less pain and lower risk of complications. [Source: 15]
:quality(75)/f/249249/1200x800/516c989596/the-minimally-invasive-surgical-instrument-market-share-by-region-in-2023.png)
:quality(75)/f/249249/1200x800/e5699bad25/the-da-vinci-system-used-in-mis-surgeries-in-china.png)
:quality(75)/f/249249/1200x800/ef431db6d3/ambulatory-surgical-centers-by-application-in-2022.png)